"10.1371_journal.pone.0034757","plos one","2012-04-24T00:00:00Z","Ashwin Patkar; William Gilmer; Chi-un Pae; Paul A VÃ¶hringer; Michael Ziffra; Edward Pirok; Molly Mulligan; Megan M Filkowski; Elizabeth A Whitham; Niki S Holtzman; Sairah B Thommi; Tanya Logvinenko; Antony Loebel; Prakash Masand; S Nassir Ghaemi","Department of Psychiatry, Duke University Medical Center, Durham, North Carolina, United States of America; Department of Psychiatry, Northwestern University, School of Medicine, Chicago, Illinois, United States of America; Mood Disorders Program, Department of Psychiatry, Tufts Medical Center, Boston, Massachusetts, United States of America; Hospital Clinico, Facultad de Medicina, Universidad Chile, Santiago, Chile; Department of Psychiatry, Emory University School of Medicine, Atlanta, Georgia, United States of America; Biostatistics Research Center at the Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, United States of America; Sunovion Pharmaceuticals, Fort Lee, New Jersey, United States of America; Tufts University School of Medicine, Boston, Massachusetts, United States of America; Graduate Program, Clinical and Translational Science Institute, Sackler School of Graduate and Biomedical Sciences, Tufts University, Boston, Massachusetts, United States of America","Conceived and designed the experiments: WG PM AL SNG AP. Performed the experiments: WG MZ CP MMF SNG EAW SBT AP MM EP. Analyzed the data: PM SNG EAW SBT NH PV TL. Contributed reagents/materials/analysis tools: SNG TL. Wrote the paper: PM SNG SBT EAW AP NH TL PV.","Dr. Ashwin Patkar is a Consultant for Bristol-Myers Squibb, GlaxoSmithKline, and Reckitt Benckiser; he is on the Speakers Bureau and received honoraria from Bristol-Myers Squibb, Cephalon/Alkermes, Pfizer, and Reckitt Benckiser; and has received Grant Support from National Institutes of Health (NIDA, NIAAA), SAMHSA, AstraZeneca, Bristol-Myers Squibb, Cephalon, Forest, GlaxoSmithKline, Janssen, Jazz Pharmaceuticals, Lundbeck, McNeil Consumer & Specialty Inc, Organon, Pfizer and Shire Pharmaceuticals. Dr. Prakash Masand is a consultant for Eli Lilly and Company, Pamlabs, Pfizer Inc., Sanofi-Aventis, and Schering Plough; he is on the Speakers Bureau for Eli Lilly and Company, Grey Healthcare, Forest Pharmaceuticals, GlaxoSmithKline, Insight Medical Communicatiions, Janssen Cilag, and Pfizer Inc.; he also has stock ownership with Orexigen Therapeutics and Titan Pharmaceuticals. Dr. William Gilmer has received honoraria and a research grant from Pfizer, and served on their Speakers Bureau. Dr. Ghaemi has received research grants from Pfizer and Sunovion and has provided research consultations for Pfizer and Sunovion. Dr. Chi-un Pae has served as a consultant for GlaxoSmithKline, Otsuka Korea Pharmaceuticals, Ltd., Eli Lilly and Company, AstraZeneca, Wyeth Korea; has served on the Speakers Bureau for Sanofi-Aventis, Schering Plough, Eli Lilly and Company, GlaxoSmithKline, AstraZeneca, Lundbeck Korea, WhanIn Pharmaceuticals, Otsuka Korea Pharmaceuticals, and Wyeth Korea; and has received grants from the Ministry for Health, Welfare and Family Affairs, KISTEP, Catholic Medical Center, The Catholic University of Korea College of Medicine Alumni, Eli Lilly and Company, GlaxoSmithKline, Otsuka Korea Pharmaceuticals, and AstraZeneca. Dr Antony Loebel is currently Executive Vice President for Clinical Research at Sunovion Pharmaceuticals. He was employed by Pfizer at the time the study was conducted. Drs. Michael Ziffra, Edward Pirok, Paul Vohringer, Molly Mulligan, Tanya Logvinenko, and Ms. Megan Filkowski, Elizabeth Whitham, Sairah Thommi, and Niki Holtzman have no conflicts to disclose. The above-stated relationships do not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","04","Ashwin Patkar","AP",15,TRUE,5,10,7,8,TRUE,FALSE,FALSE,0,NA,FALSE
